The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

So which legitimate weight-loss pills are on the market, by prescription and over the counter? Do they work, and if so, how and for who? Whether taken orally or by injection, all regulated weight ...

Pharma firms like Lilly, Roche and Pfizer are racing to develop weight loss pills. Blockbuster injections like Ozempic, Wegovy, Mounjaro and Zepbound—brand names for the drugs semaglutide and ...

Participants on the highest dose of the pill lost an average of 16 pounds, or nearly 8% of their body weight. This level of weight loss is consistent with the amount shed over the same period ...

The pill, poised to revolutionize the weight loss world, may be up for FDA approval in late 2025. A daily pill to rival Ozempic is one step closer to hitting the market. Pharmaceutical giant Eli ...

That medication has been available by prescription since 2019 for the treatment of Type 2 diabetes but is not FDA-approved for weight loss. GLP-1 pills can be a promising option for people with ...

Now, a new contender is stepping into the spotlight. It’s called Orforglipron, and it’s a daily weight loss pill that could be a game-changer in how we manage both weight and blood sugar.

FRIDAY, April 18, 2025 (HealthDay News) — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug ...

70. Novo Nordisk on Tuesday reported that its new obesity pill that targets the amylin hormone led to substantial weight loss in an early study, boosting the company’s pipeline of next ...

Lilly said weight loss hadn’t plateaued at the time the study ended, suggesting that patients might lose more weight. The pill lowered blood sugar levels by an average of 1.3%. Ozempic lowered ...